Clinical Case Reports
Mesalazine‐Induced Myocarditis: A Challenging Diagnostic Journey
By Mohamed Zakaria Bouayed, Iliass Benaini, Hajar Koulali and 5 others.
Abstract
ABSTRACT Mesalazine‐induced myocarditis, though rare, should be suspected in patients presenting with acute chest pain and elevated cardiac biomarkers shortly after treatment initiation. Cardiac MRI plays a pivotal role in diagnosis. Prompt drug discontinuation often leads to rapid clinical recovery, highlighting the importance of early recognition to prevent severe complications.
Keywords
- acute myocarditis
- adverse drug reaction
- cardiac magnetic resonance imaging
- drug‐induced myocarditis
- inflammatory bowel disease
- mesalazine
Source
Published in Clinical Case Reports. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
